| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
68,788,000 |
| Market
Cap: |
2.17(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$14.19 - $52.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Arvinas is a biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies to degrade disease-causing proteins. Co. is developing ARV-110, a proteolysis targeting chimeras (PROTAC) targeted protein degrader targeting the androgen receptor protein for the treatment of men with metastatic castration-resistant prostate cancer. Co. is also developing ARV-471, a PROTAC targeted protein degrader targeting the estrogen receptor protein, or ER, for the treatment of patients with locally advanced or metastatic ER positive / HER2 negative breast cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
10,298 |
10,298 |
11,622 |
21,554 |
| Total Sell Value |
$484,521 |
$484,521 |
$516,810 |
$859,747 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
4 |
4 |
5 |
9 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Schwab Andrew J. |
10% Owner |
– – • |
2019-06-07 |
4 |
S |
$19.65 |
$3,733,500 |
I/I |
(190,000) |
111,513 |
|
- |
|
| Taylor Ian |
Chief Scientific Officer |
• – – |
2019-03-29 |
4 |
B |
$14.66 |
$14,660 |
D/D |
1,000 |
85,496 |
2.74 |
- |
|
| Shannon Timothy M |
Director |
– • – |
2019-03-28 |
4 |
B |
$14.69 |
$51,410 |
D/D |
3,500 |
58,898 |
2.39 |
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2019-03-28 |
4 |
S |
$14.16 |
$5,112,684 |
I/I |
(361,129) |
116,287 |
|
- |
|
| Bettigole Robert A. |
Former 10% owner |
– – – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
767,623 |
767,623 |
|
- |
|
| Houston John G |
President and CEO |
• • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,484 |
785,344 |
|
- |
|
| Houston John G |
President and CEO |
• • – |
2018-10-01 |
4 |
B |
$16.00 |
$480,000 |
D/D |
30,000 |
772,860 |
2.81 |
- |
|
| Canaan Partners Ix Llc |
10% Owner |
– – • |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,989,554 |
4,989,554 |
|
- |
|
| Kennedy Edward Moore Jr. |
Director |
– • – |
2018-10-01 |
4 |
B |
$16.00 |
$336,000 |
D/D |
21,000 |
34,385 |
2.39 |
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
I/I |
4,989,552 |
125,360 |
|
- |
|
| Loven Jakob |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,381,851 |
1,694,351 |
|
- |
|
| Loven Jakob |
Director |
– • – |
2018-10-01 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
312,500 |
2.1 |
- |
|
| Shannon Timothy M |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
I/I |
4,989,554 |
4,989,554 |
|
- |
|
| Shannon Timothy M |
Director |
– • – |
2018-10-01 |
4 |
B |
$16.00 |
$64,000 |
D/D |
4,000 |
55,398 |
2.39 |
- |
|
| Kolchinsky Peter |
Former 10% Owner |
– – – |
2018-10-01 |
4 |
B |
$16.00 |
$16,000,000 |
I/I |
1,000,000 |
3,138,412 |
0.01 |
- |
|
| Kolchinsky Peter |
Former 10% Owner |
– – – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
I/I |
2,138,412 |
2,138,412 |
|
- |
|
| Ratcliffe Liam |
Director |
– • – |
2018-10-01 |
4 |
B |
$16.00 |
$16,000,000 |
I/I |
1,000,000 |
375,000 |
2.1 |
- |
|
| Ratcliffe Liam |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,283,048 |
1,283,048 |
|
- |
|
| Margus Bradley Albert |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
I/I |
42,768 |
42,768 |
|
- |
|
| Margus Bradley Albert |
Director |
– • – |
2018-10-01 |
4 |
B |
$16.00 |
$640,000 |
D/D |
40,000 |
99,463 |
2.39 |
- |
|
| Cassidy Sean A |
Chief Financial Officer |
• – – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,345 |
174,810 |
|
- |
|
| Cassidy Sean A |
Chief Financial Officer |
• – – |
2018-10-01 |
4 |
B |
$16.00 |
$25,600 |
D/D |
1,600 |
169,465 |
2.74 |
- |
|
| Deerfield Private Design Fund Iv, L.p. |
Possible Member of a 10% Group |
– – • |
2018-10-01 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
411,244 |
1.5 |
- |
|
| Deerfield Private Design Fund Iv, L.p. |
Possible Member of a 10% Group |
– – • |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
I/I |
921,234 |
307,078 |
|
- |
|
174 Records found
|
|
Page 7 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.13 (0.41%) 
